Gypenoside XVII protects against spinal cord injury in mice by regulating the microRNA-21-mediated PTEN/AKT/mTOR pathway

Gypenoside XVII (GP-17), one of the dominant active components of Gynostemma pentaphyllum, has been studied extensively and found to have a variety of pharmacological effects, including neuroprotective properties. However, the neuroprotective effects of GP-17 against spinal cord injury (SCI), as wel...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Tianyu, Duan, Liying, Li, Jiaju, Guo, Hongyu, Xiong, Mingyue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208621/
https://www.ncbi.nlm.nih.gov/pubmed/34132355
http://dx.doi.org/10.3892/ijmm.2021.4979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8208621/
https://www.ncbi.nlm.nih.gov/pubmed/34132355
http://dx.doi.org/10.3892/ijmm.2021.4979

Ejemplares similares